CClinicalTrials.gg
CompletedNCT01532037Updated Jun 23, 2021

Self Help for Fatigue in Multiple Sclerosis

An interventional study of Cognitive behavioural therapy based self help and Treatment as usual in Multiple Sclerosis and Fatigue, sponsored by University of Edinburgh. Completed at 2 sites in United Kingdom. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-06-23.

Sponsored by University of Edinburgh · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
73
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to determine if cognitive behavioural therapy (CBT) based self help is effective for the management of symptoms of fatigue in Multiple Sclerosis (MS).

Read the detailed description

Background: Fatigue is a common disabling symptom in patients with Multiple Sclerosis (MS). Cognitive behavioural therapy (CBT) has been shown to be effective in the reduction of fatigue in MS and CBT-based self-help has been shown to be effective as a low intensity intervention for anxiety and depression.

Objectives: To evaluate the effectiveness of a CBT based self-help workbook at reducing perceived impact of fatigue in a clinical sample of MS patients.

02

Conditions studied

  • Multiple Sclerosis
  • Fatigue

Keywords

  • Randomised controlled trial
  • Multiple Sclerosis
  • Fatigue
  • Cognitive Behavioural Therapy
  • Self Help
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 73 is above the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

University of Edinburgh is the lead sponsor of 393 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All participants will be aged 18 or over
  • Will have a recognised diagnosis of relapsing remitting or primary progressive relapsing remitting Multiple Sclerosis from a neurologist
  • Cognitively able to give informed consent as deemed by referring clinician in the Fife Rehabilitation Service
  • Willing to consent to randomised control trial
  • Fatigue as a primary symptom

Exclusion criteria

Exclusion Criteria:

  • Patients with severe anxiety or depression (assessed by cut off on HADS)
  • Patients with psychosis or personality disorders (assessed by referring clinician)
  • Patients currently receiving input from psychological services for fatigue management
  • Patients with suicidal ideation or plans (assessed by referring clinician)
  • Patients who are unable to read the workbook or standardised questionnaires due to literacy levels or cognitive abilities will be excluded from the analysis, although if patients have literacy or cognitive problems, referral to a more suitable 1-to-1 type of therapy will be made.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
73 participants (actual)

Study arms

  • Experimental
    Guided Self Help

    Participant receives usual care and 4, 45 minute sessions with a therapist to support them to complete the cognitive behavioural therapy based workbook for fatigue in Multiple Sclerosis.

    Other: Cognitive behavioural therapy based self help

  • Experimental
    Pure Self Help

    Participant receives usual care and cognitive behavioural therapy based self help work book for fatigue in multiple sclerosis to complete alone

    Other: Cognitive behavioural therapy based self help

  • Placebo comparator
    Treatment as Usual

    Participants receive usual care from healthcare professionals

    Other: Treatment as usual

Interventions

  • OtherCognitive behavioural therapy based self help

    Comparison of cognitive behavioural therapy based pure self help and guided self help (support of a therapist) compared to treatment as usual

  • OtherTreatment as usual

    Usual care from healthcare professionals with regard to patients symptoms of fatigue

06

What researchers measure

Primary outcomes

  1. Change from baseline on ratings of the Modified Fatigue Impact Scale at post measure, 3, 6 & 12 months follow up.

    The Modified Fatigue Impact Scale (MFIS) consists of 21 items selected from the Fatigue Impact Scale (FIS; Fisk, Ritvo, Ross, Haase, Murray, \& Schlech, 1994), a multidimensional scale developed to assess the perceived impact of fatigue on a variety of daily activities. The items of the MFIS can be combined into three subscales (Physical, Cognitive, and Psychosocial), as well as into a total MFIS score. All items are scaled so that higher scores indicate a greater impact of fatigue on a patient's activities. Measures will be taken at 5 time points to assess change over time.

    Time frame: 5 time points at 0, 8, 20, 32 & 60 weeks.

Secondary outcomes

  1. Change from baseline on the 36-Item Short Form Survey Instrument at post measure, 3, 6 and 12 months follow up.

    36-Item Short Form Survey Instrument (SF 36, Ware et al.1993) consists of 36 questions measuring functional health and well-being from the patient's point of view. Scores are split into two summary measures (physical health and mental health) and within the two summary measures there are eight scales which include. The eight scales are made up of; physical functioning, role limitations due to physical functioning, bodily pain, general health, vitality, social functioning, role limitations due to emotional functioning and mental health.

    Time frame: 5 time points at 0, 8, 20, 32 & 60 weeks

  2. Change from baseline on the Hospital Anxiety and Depression Scale at post measure, 3, 6 and 12 months follow up.

    Time frame: 5 time points at 0, 8, 20, 32 & 60 weeks

  3. Change from baseline on the Self-Efficacy for managing chronic Disease 6 Item Scale at post measure, 3, 6 and 12 months follow up.

    Is a 6-item scale which is adapted from the original 33 item scale (Lorig et al. 1996). The 6-item scale was developed so it would be less burdensome for patients. The 6- item scale covers areas of symptom control, role function, emotional functioning and communicating with physicians.

    Time frame: 5 time points at 0, 8, 20, 32 & 60 weeks

07

Study locations

2 sites
  • Fife Rehabilitation Service
    Leven, Scotland KY8 5RR, United Kingdom
  • NHS Fife
    Leven, Scotland KY8 5RR, United Kingdom
08

References and documents

Publications

  • Chapter 4 in https://era.ed.ac.uk/bitstream/handle/1842/21011/Gallen2015.pdf
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01532037
Lead sponsor
University of Edinburgh
Responsible party
Sponsor
First posted
Feb 13, 2012
Start date
Jun 2012
Primary completion
May 2014
Completion
May 2014
Last update
Jun 23, 2021

Study contacts

Kirsty Nesbitt
principal investigator · National Health Service, University of Edinburgh

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion